| CXSL1400077 | 注射用重组抗人表皮生长因子受体2(HER2)单抗(曲妥珠单抗) | trastuzumab | Lyophilized | Biological Products(2) | New Drug Application | 2014-09-12 | 华兰基因工程有限公司 | Hualan Genetic Engineering Co Ltd | Certificate Issued | 2016-07-21 | view |
| CXSL1800055 | 重组抗CTLA-4全人源单克隆抗体注射液 | | Injection | Biological Products(2) | New Drug Application | 2018-05-21 | 华兰基因工程有限公司 | Hualan Genetic Engineering Co Ltd | Certificate Issued | 2018-10-08 | view |
| CXSL1800077 | 重组抗EGFR全人源单克隆抗体注射液 | | Injection | Biological Products(2) | New Drug Application | 2018-07-25 | 华兰基因工程有限公司 | Hualan Genetic Engineering Co Ltd | Certificate Issued | 2018-11-01 | view |
| CXSL1700110 | 重组抗RANKL全人源单克隆抗体注射液 | denosumab | Injection | Biological Products(2) | New Drug Application | 2017-12-25 | 华兰基因工程有限公司 | Hualan Genetic Engineering Co Ltd | Certificate Issued | 2018-10-08 | view |
| CXSL1400139 | 重组抗人肿瘤坏死因子(TNFα)单抗注射液(阿达木单抗) | adalimumab | Injection | Biological Products(2) | New Drug Application | 2015-02-03 | 华兰基因工程有限公司 | Hualan Genetic Engineering Co Ltd | Certificate Issued | 2017-02-13 | view |
| CXSL1400096 | 重组抗淋巴细胞瘤(CD20)单抗注射液(利妥昔单抗) | rituximab | Injection | Biological Products(2) | New Drug Application | 2014-11-17 | 华兰基因工程有限公司 | Hualan Genetic Engineering Co Ltd | Certificate Issued | 2016-12-08 | view |
| CXSL1400094 | 重组抗血管内皮生长因子(VEGF)单抗注射液(贝伐单抗) | bevacizumab | Injection | Biological Products(2) | New Drug Application | 2014-11-17 | 华兰基因工程有限公司 | Hualan Genetic Engineering Co Ltd | Certificate Issued | 2016-08-23 | view |
| CXSL1900010 | 重组抗血管内皮生长因子（VEGF）单抗注射液 | bevacizumab | Injection | Biological Products(2) | New Drug Application | 2019-02-19 | 华兰基因工程有限公司 | Hualan Genetic Engineering Co Ltd | In Review | 2019-02-18 | view |
